INPLASY202630015

Predictive Value of PD-L1 Expression and dMMR/pMMR Status for Immune Checkpoint Inhibitor Combined with Chemotherapy in Advanced/Recurrent Endometrial Cancer: A Meta-Analysis

Keywords: endometrial cancer; immune checkpoint inhibitor; PD-L1; deficient mismatch repair (dMMR); proficient mismatch repair (pMMR); meta-analysis.

Read and download full-text here - PDF 202630015

Review Status: ongoing